Amy E. Colson
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 13
- HIV/AIDS Research and Interventions 4
- Otolaryngology and Infectious Diseases 1
-
- HIV-related health complications and treatments 2
- Co-authors
- Peter W. Choo (2 shared papers)Paul Edward Sax (2 shared papers)Marla J. Keller (2 shared papers)Gene D. Morse (1 shared paper)Calvin J. Cohen (2 shared papers)Richard Platt (1 shared paper)Michael S. Saag (1 shared paper)Marcus A. Conant (1 shared paper)
- Journals
- The Lancet (2 papers)Clinical Infectious Diseases (2 papers)AIDS (2 papers)HIV Clinical Trials (2 papers)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Amy E. Colson
14 papers receiving 711 citations
Amy E. Colson's Hit Papers
Peers
Comparison fields: 5 of 43
- Hepatology 355
- Infectious Diseases 306
- Virology 20
- Psychiatry and Mental health 42
- Emergency Medicine 17
Countries citing papers authored by Amy E. Colson
This map shows the geographic impact of Amy E. Colson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Colson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Colson more than expected).
Fields of papers citing papers by Amy E. Colson
This network shows the impact of papers produced by Amy E. Colson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Colson. The network helps show where Amy E. Colson may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Colson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1 Hit paper breakdown → | 2015 | 388 |
| 2 | 2007 | 102 | |
| 3 | 2000 | 76 | |
| 4 | 2007 | 70 | |
| 5 | 2002 | 65 | |
| 6 | 1999 | 18 | |
| 7 | 2001 | 13 | |
| 8 | 2026 | 7 | |
| 9 | 2011 | 5 | |
| 10 | 2025 | 5 | |
| 11 | 2025 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2026 | 0 |
About Amy E. Colson
Amy E. Colson is a scholar working on Infectious Diseases, Emergency Medicine, Virology, Hepatology and Ophthalmology, having authored 15 papers that have together received 761 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (2 papers), Otolaryngology and Infectious Diseases (1 paper), HIV Research and Treatment (1 paper), Hepatitis C virus research (1 paper), Nail Diseases and Treatments (1 paper) and Cerebral Venous Sinus Thrombosis (1 paper). The work is most often cited by research in Hepatology (355 citations), Infectious Diseases (306 citations), Virology (20 citations), Psychiatry and Mental health (42 citations) and Emergency Medicine (17 citations). Amy E. Colson has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Peter W. Choo, Paul Edward Sax, Marla J. Keller, Gene D. Morse, Calvin J. Cohen, Richard Platt, Michael S. Saag, Marcus A. Conant, Eric A Lefebvre and Richard Haubrich. Their work appears in journals such as The Lancet, Clinical Infectious Diseases, AIDS, HIV Clinical Trials and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.